Emerging Markets Regulatory Tracker: Australia, Brazil, India (Vol. 4 No. 23)
This article was originally published in PharmAsia News
Australia’s TGA proposes new warning labels for pediatric OTC cough medicines and decongestants. Brazil requires 12-month notice before withdrawing products from the market and India’s CDSCO specifies format for fixed-dose combination drug submissions.